Featured Research

from universities, journals, and other organizations

'Explosion' of new therapies for neurologic conditions

Date:
August 15, 2013
Source:
Loyola University Health System
Summary:
There has been an “explosion of new and innovative” therapies for neurologic conditions such as stroke, epilepsy, Parkinson disease and multiple sclerosis, a top neurologist reports.

There has been an “explosion of new and innovative” therapies for neurologic conditions such as stroke, epilepsy, Parkinson disease and multiple sclerosis, Loyola University Medical Center neurologist Dr. Jose Biller writes in the August issue of the journal Neurologic Clinics.

Biller is editor of the August issue, which includes 14 articles describing the latest data on new and emerging therapies for neurologic conditions. Five of the articles are written by Loyola physicians:

Sarkis Morales Vidal, MD and Sean Ruland, DO: “Platelet Antiaggregants in Stroke Prevention.”

Adriana Sofia Ploneda Perilla and Michael J. Schneck, MD: “Unanswered Questions in Thrombolytic Therapy for Acute Ischemic Stroke.”

Michael Star, MD and Murray Flaster, MD, PhD: “Advances and Controversies in the Management of Cerebral Venous Thrombosis.”

Jorge J. Asconape: “Epilepsy.”

Douglas Anderson, MD and Ninith Kartha, MD: “Deep Brain Stimulation in Nonparkinsonian Movement Disorders and Emerging Technologies, Targets and Therapeutic Promises in Deep Brain Stimulation.”

Matthew McCoyd, MD: “Update on Therapeutic Options for Multiple Sclerosis.”

In the preface, Biller writes that the August issue of Neurologic Clinics is intended to provide timely and practical information to physicians treating neurologic disorders. He concludes: “There is every reason to believe that future advances in neurologic therapy are sure to come.”

Biller is chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jos Biller. Preface. Neurologic Clinics, 2013; 31 (3): xiii DOI: 10.1016/j.ncl.2013.04.015

Cite This Page:

Loyola University Health System. "'Explosion' of new therapies for neurologic conditions." ScienceDaily. ScienceDaily, 15 August 2013. <www.sciencedaily.com/releases/2013/08/130815104853.htm>.
Loyola University Health System. (2013, August 15). 'Explosion' of new therapies for neurologic conditions. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2013/08/130815104853.htm
Loyola University Health System. "'Explosion' of new therapies for neurologic conditions." ScienceDaily. www.sciencedaily.com/releases/2013/08/130815104853.htm (accessed July 29, 2014).

Share This




More Mind & Brain News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins